Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKinsey
Mallinckrodt
Farmers Insurance
Chinese Patent Office
Accenture
Colorcon
Covington
Fuji

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084267

« Back to Dashboard

NDA 084267 describes TRIAMCINOLONE, which is a drug marketed by Barr, Impax Labs, Ivax Sub Teva Pharms, Mylan, Purepac Pharm, Roxane, Sandoz, Teva, Watson Labs, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Fougera Pharms, G And W Labs, Glenmark Pharms Ltd, Lupin Atlantis, Morton Grove, Mylan Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Teligent Pharma Inc, Topiderm, Vintage, Amneal Pharms Co, Parnell, Sandoz Inc, Akorn, G And W Labs Inc, Wockhardt Bio Ag, Glenmark Pharms, Lyne, Perrigo Israel, Perrigo Uk Finco, Riconpharma Llc, and Cmp Pharma Inc, and is included in ninety-nine NDAs. Additional details are available on the TRIAMCINOLONE profile page.

The generic ingredient in TRIAMCINOLONE is triamcinolone diacetate. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone diacetate profile page.
Summary for 084267
Tradename:TRIAMCINOLONE
Applicant:Barr
Ingredient:triamcinolone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084267

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Accenture
Harvard Business School
Healthtrust
Mallinckrodt
McKinsey
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.